Research Topics
| P W ArmstrongSummaryAffiliation: University of Alberta Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS dataPaul W Armstrong
University of Alberta, Edmonton, Alta
CMAJ 174:1421-6. 2006..We undertook a prespecified pooled analysis of data from the ASSENT-3 and ASSENT-3 PLUS trials...
Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impactP W Armstrong
Department of Medicine, University of Alberta, Edmonton, Canada
Can J Cardiol 13:507-16. 1997....
Balancing the cyclooxygenase portfolioPaul W Armstrong
Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 174:1581-2. 2006
Defining myocardial infarction: a work in progress: Ischaemic heart diseasePaul W Armstrong
Division of Cardiology, University of Alberta, 2-51 Medical Sciences Building, Edmonton, Alberta T6G 2H7, Canada
Heart 94:1076-9. 2008
A time for transformative leadership in academic health sciencesPaul W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Clin Invest Med 30:E127-32. 2007....
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudyPaul W Armstrong
University of Alberta, Edmonton, AB T6G 2H7, Canada
Circulation 125:514-21. 2012....
Ruminating on OAT: is the case closed?Paul W Armstrong
University of Alberta Edmonton, Alberta, T6G 2H7 Canada
Eur Heart J 28:531-2. 2007
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intPaul W Armstrong
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am Heart J 149:402-7. 2005
Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fitPaul W Armstrong
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 169:925-7. 2003
Do guidelines influence practice?Paul W Armstrong
University of Alberta, Edmonton, Alberta, T6G 2H7, Canada
Heart 89:349-52. 2003
A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) studyPaul W Armstrong
Canadian VIGOUR Centre, 2 51 Medical Sciences Building, University of Alberta Edmonton, AB, Canada T6G 2H7
Eur Heart J 27:1530-8. 2006..We evaluated whether optimal pharmacologic therapy at the earliest point of care, emphasizing pre-hospital randomization and treatment was non-inferior to expeditious primary percutaneous coronary intervention (PCI)...
Advancing interdisciplinary health research: a synergism not to be deniedPaul W Armstrong
Department of Medicine, University of Alberta, Edmonton, Alta
CMAJ 175:761. 2006
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trialPaul W Armstrong
University of Alberta, Edmonton, Alberta, T6G 2H7 Canada
JAMA 297:43-51. 2007..However, in patients without prompt reestablishment of brisk coronary flow and tissue perfusion, mortality remains high, providing an opportunity for novel treatments, including anti-inflammatory agents...
Fibrinolysis for acute myocardial infarction: the future is here and nowPaul W Armstrong
Department of Medicine, 2-51 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
Circulation 107:2533-7. 2003
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarctionPaul W Armstrong
University of Alberta, Edmonton, Canada
Eur Heart J 24:1515-22. 2003..We compared ST resolution in each of the three treatment regimens in order to evaluate the speed, extent and stability of ST segment resolution and its relationship to the primary composite endpoint(s) of the trial...
A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trialPaul W Armstrong
Department of Medicine, Division of Cardiology, University of Alberta, Edmonton, Alberta
Can J Cardiol 24:30B-2B. 2008..The trial is embedded in an academic research organization motif and promises to provide a significant contribution to the body of knowledge in acute heart failure and the care of patients so afflicted...
Evolution of the CCU from rhythm, function and protection to reperfusion and beyond: a personal journey and perspectiveP W Armstrong
Department of Medicine, University of Alberta, Edmonton
Can J Cardiol 12:909-13. 1996..To trace the evolution of coronary care and the management of acute coronary syndromes...
The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working GroupPaul W Armstrong
VIGOUR Centre, University of Alberta, Edmonton
Can J Cardiol 20:1075-9. 2004....
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Circulation 98:1860-8. 1998..This issue has not been studied systematically among the spectrum of patients with acute coronary presentations, encompassing those with and without ST-segment elevation...
Reperfusion paradox in ST-segment elevation myocardial infarctionPaul W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Ann Intern Med 155:389-91. 2011..The authors believe it is time to embrace an integrated dual reperfusion strategy to best serve all patients with STEMI...
Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS)P W Armstrong
University of Alberta, Edmonton, Canada
Am Heart J 139:820-3. 2000..We undertook an angiographic, dose-finding study of staphylokinase (SAK42D variant) to evaluate its efficacy and safety in patients with acute ST-segment myocardial infarction...
Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trialPaul W Armstrong
University of Alberta, Edmonton, Canada
Am Heart J 161:848-54. 2011..Traditional time-to-event analysis assigns equal weight to the first event in the composite end point. This is counterintuitive to many stakeholders...
Lessons learned from a clinical trialPaul W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Circulation 110:3610-4. 2004
Innovative strategic Canadian research training from TomorrOw's Research Cardiovascular Health Care Professionals (TORCH)Paul W Armstrong
University of Alberta, Edmonton, Alta
Clin Invest Med 27:33-41. 2004..The program has recruited 19 trainees from a broad cross-section of disciplines, integrating 2 University of Alberta campuses. The preliminary experience has been both favourable and gratifying...
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarctionPaul W Armstrong
The University of Alberta, Edmonton, Alberta, Canada
Am Heart J 151:787-90. 2006....
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) studyPaul W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 160:30-35.e1. 2010....
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong
University of Alberta, Edmonton, Canada
J Am Coll Cardiol 53:1503-9. 2009..We assessed the incremental value of baseline Q waves over time from symptom onset as a marker of clinical outcome in ST-segment elevation myocardial infarction (STEMI)...
Coronary reperfusion: numerators searching for denominatorsPaul W Armstrong
Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Lancet 359:371-2. 2002
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II)P W Armstrong
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 146:484-8. 2003..Pilot studies with bolus pegulated staphylokinase (PEG-Sak) have revealed excellent Thrombolysis In Myocardial Infarction (TIMI) 3 60-minute flow...
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul
University of Alberta, Edmonton, Canada
J Am Coll Cardiol 38:64-71. 2001..CONCLUSIONS: These data provide new evidence supporting the powerful prognostic value of the baseline electrocardiogram and, in particular, the magnitude and distribution of ST segment depression in predicting unfavorable events...
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trialR C Welsh
University of Alberta, Edmonton, Alberta, Canada
Heart 91:1400-6. 2005....
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trialY Fu
University of Alberta, Edmonton, Alberta, Canada
Circulation 104:2653-9. 2001..Time to treatment further differentiates between high- and low-risk patients and further highlights the importance of reducing time delay to initiation of fibrinolysis in acute myocardial infarction...
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I AS G Goodman
The Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario, Canada
Circulation 97:444-50. 1998....
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul
University of Alberta, Edmonton, Alberta, Canada
Heart 91:876-81. 2005..To examine whether ST segment depression influenced clinical decision making and whether there was international variation in the use of cardiac procedures across ST segment depression categories...
A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-studyRobert C Welsh
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Catheter Cardiovasc Interv 70:341-8. 2007..To evaluate the anticoagulation effect of subcutaneous (SQ) and intravenous (IV) enoxaparin through systematic anti-Xa sampling during primary PCI for acute STEMI...
Impact of sex on long-term mortality from acute myocardial infarction vs unstable anginaWei-Ching Chang
Department of Medicine, University of Alberta, Edmonton, Canada
Arch Intern Med 163:2476-84. 2003..Additional investigation into the causes, treatment, and policy implications of the age-sex interaction is warranted...
Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?Sumit R Majumdar
Division of General Internal Medicine, Department of Medicine, University of Alberta, Edmonton, Canada
Am J Med 113:140-5. 2002....
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT TrialW C Chang
University of Alberta, Edmonton, Alberta, Canada
Eur Heart J 23:1102-11. 2002....
Randomised trials of secondary prevention programmes in coronary heart disease: systematic reviewF A McAlister
Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alberta, Canada
BMJ 323:957-62. 2001..To determine whether multidisciplinary disease management programmes for patients with coronary heart disease improve processes of care and reduce morbidity and mortality...
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi
University of Alberta, 2 51 Medical Science Building, Edmonton, Canada T6G 2H7
Eur Heart J 24:522-31. 2003....
Do cardiac troponins provide prognostic insight in hemodialysis patients?Jonathan B Choy
Division of Cardiology, University of Alberta Hospital, Edmonton, Canada
Can J Cardiol 19:907-11. 2003..The relative incidence of elevated cardiac troponins in this population and their relationship to clinical events remain unknown...
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failureJustin A Ezekowitz
Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
Circulation 107:223-5. 2003..Further research into the mechanisms of anemia in CHF and randomized controlled trials to test whether correction of anemia improves prognosis in CHF are needed...
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatideShaun G Goodman
Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Circulation 107:238-44. 2003..A key issue of uncertainty is the safety and efficacy of combination glycoprotein IIb/IIIa inhibitor and low-molecular-weight heparin therapy...
A marriage of enhancement: fibrinolysis and conjunctive therapyRobert C Welsh
The University of Alberta, Department of Medicine, Division of Cardiology, Edmonton, AB T6G 2H7 Canada
Thromb Haemost 92:1194-200. 2004..The future is likely to emphasize greater application of the already effective therapies at our disposal and the development of novel anti-platelet and anti-thrombin agents as well as those directed toward inflammation...
Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care surveyRobert C Welsh
University of Albert, Edmonton, Canada
Eur J Emerg Med 11:134-40. 2004....
Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American centerRobert C Welsh
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 152:1007-14. 2006....
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz
University of Alberta, Edmonton, Canada
Can J Cardiol 22:393-7. 2006..NT-proBNP at baseline, 24 h and 72 h after presentation with acute STEMI, is an independent predictor of a poor outcome and adds clinically useful prognostic information...
Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary eventMichelle M Graham
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am Heart J 156:1210-1216.e1. 2008..We used population-level data to determine the rate at which such patients seek medical attention for these symptoms, whether sex differences are present, and if an association between prodromes and 1-year mortality exists...
Interinstitutional variation in the use of abciximab for percutaneous coronary interventionCynthia M Westerhout
Department of Public Health Sciences, University of Alberta, Edmonton
Can J Cardiol 20:405-10. 2004..The absence of provincial or national guidelines may have influenced the uptake and application of this novel therapy...
Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic eraShaun G Goodman
Division of Cardiology, Canadian Heart Research Center, St Michael s Hospital, Toronto, Ontario, Canada
Am Heart J 144:243-50. 2002..Data on non-Q myocardial infarctions (MI) are derived primarily from prethrombolytic era studies. Previous trials demonstrated different development rates and none reported on clinical outcomes...
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 148:62-71. 2004..82 for the composite and day 7-30 models, respectively. CONCLUSIONS: Dynamic risk assessment is feasible and reliable. This approach can improve risk assessment and provide valuable guidance for management of patients with NSTE-ACS...
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey
University of Alberta, Edmonton, Alberta, Canada
Heart 95:1331-6. 2009..Spontaneous reperfusion (SR) in ST elevation myocardial infarction (STEMI) improves clinical outcome, yet its incidence and impact among diabetic patients is unclear...
The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2Michael C Tjandrawidjaja
Department of Medicine, Division of Cardiology, 2-51 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada
Eur Heart J 24:1024-34. 2003..CONCLUSION: Women with early reinfarction following fibrinolysis for AMI had more frequent early death and were managed less aggressively. These findings suggest the need for increased awareness and timely intervention in these patients...
Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction TrialSean van Diepen
Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
J Electrocardiol 43:351-8. 2010..Hence, in STEMI patients treated with primary percutaneous coronary intervention, we examined whether baseline atrial electrocardiographic changes or atrial infarction patterns predicted new AF or mortality...
Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMIMichael C Tjandrawidjaja
Division of Cardiology, Department of Medicine, University of Alberta, 2 51 Medical Sciences Building, Edmonton, Alberta T6G 2H7, Canada
Eur Heart J 28:2850-7. 2007..To examine the extent and impact on clinical outcomes of adherence to electrocardiogram (ECG) entry criteria in ST-elevation myocardial infarction patients in the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial...
Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromesBrian Y L Wong
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 144:987-94. 2002..Accordingly, we evaluated plasma samples acquired at presentation in 178 patients with ACS for a possible association between Cpn IgA titer and biochemical evidence of myocardial injury...
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic SubstudyTaha Taher
University of Alberta, Edmonton, Alberta, Canada
J Am Coll Cardiol 44:38-43. 2004..002). CONCLUSIONS: Prompt fibrinolytic treatment improved the likelihood of aborted MI. The subgroup with complete 60-min ST-segment resolution had the best clinical outcomes...
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteriaMustafa Toma
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Am J Cardiol 97:882-5. 2006..Thus, the development and validation of a risk stratification scheme to identify those patients most likely to benefit from ICDs for primary prophylaxis should be a research priority...
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarctionWei-Ching Chang
Department of Medicine, University of Alberta, 2-51 Medical Sciences Building, Edmonton, Alberta, Canada T6G 2H7
Eur Heart J 27:419-26. 2006..g. the identification of high-risk patients for possible co-interventions. CONCLUSION: Dynamic modelling for STEMI patients enhances the risk assessment and stratification and should provide valuable ongoing guidance for their management...
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysisWei Ching Chang
University of Alberta, Edmonton, Alberta T6G 2H7, Canada
J Epidemiol Community Health 59:427-33. 2005..The relative contributions of patient, hospital, and country level factors on clinical outcomes, however, remain unclear, and thus, was the objective of this study...
Impact of specialist follow-up in outpatients with congestive heart failureJustin A Ezekowitz
Division of Cardiology, University of Alberta, Edmonton, Alta
CMAJ 172:189-94. 2005..Methods to improve timely and appropriate access to specialists and to improve collaborative care structures are needed...
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudyMichael A McDonald
Division of Cardiology, University of Alberta, 251 Medical Sciences Building, Edmonton, Alberta, Canada T6G 2H7
Eur Heart J 29:871-9. 2008..Patients in ASSENT-4 PCI undergoing tenecteplase-facilitated percutaneous coronary intervention (PCI) had more adverse events than those undergoing primary PCI. We analysed this to gain further insights...
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryEric J Velazquez
Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
Eur Heart J 25:1911-9. 2004....
Usefulness of spironolactone in a specialized heart failure clinicWendy Sligl
Division of General Internal Medicine, Edmonton, Alberta, Canada
Am J Cardiol 94:443-7. 2004..Thus, although the complication rate was higher, the benefits of spironolactone seen in RALES extended to participants not in a trial who were treated with similar doses and followed closely in a clinic specializing in heart failure...
Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North AmericaRobert C Welsh
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 145:1-8. 2003..We review past research in prehospital therapy for STEMI and practical impediments to implementation to establish a framework for interpretation of future developments...
It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarctionR C Welsh
University of Alberta, Edmonton, Alberta, Canada
Heart 91:1524-6. 2005
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experienceShaun G Goodman
The Canadian Heart Research Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Canada
Am Heart J 152:277-84. 2006....
Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarctionMichael C Tjandrawidjaja
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
J Electrocardiol 38:271-8. 2005..1% vs 3.6%; P = .001). CONCLUSION: These findings support the etiological role of acute atrial ischemia in the development of early atrial arrhythmias and AV block complicating AMI...
Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessmentsKevin R Bainey
University of Alberta, Edmonton, Alberta, Canada
Am Heart J 156:248-55. 2008....
The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomesPuneeta Tandon
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Arch Intern Med 164:769-74. 2004..In our cohort of elderly patients with multiple comorbidities, beta-blockers were well tolerated...
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionMichael C Tjandrawidjaja
University of Alberta, Edmonton, Canada
Am J Cardiol 106:630-4. 2010..24, HR for death/CHF/shock 2.93, 95% CI 1.84 to 4.67). In conclusion, infarct size as estimated by QRS scoring at hospital discharge is an independent and prognostically relevant metric in patients with STEMI undergoing primary PCI...
Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Sumit R Majumdar
Division of General Internal Medicine, Department of Medicine, University of Alberta, 251 Medical Sciences Building, Edmonton, Alberta, Canada T6G 2H7
Clin Ther 26:694-703. 2004....
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionRobert C Welsh
University of Alberta, Edmonton, Alberta, Canada
JACC Cardiovasc Interv 3:343-51. 2010..We sought to compare outcomes in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) with or without previous coronary artery bypass grafts (CABG)...
Effects of socioeconomic status on mortality after acute myocardial infarctionWei Ching Chang
University of Alberta, Edmonton, Alberta, Canada
Am J Med 120:33-9. 2007..To assess the effects of socioeconomic status on mortality in patients with acute myocardial infarction...
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkersCynthia M Westerhout
University of Alberta, Edmonton, Canada
J Am Coll Cardiol 48:939-47. 2006..The purpose of this study was to develop 30-day and 1-year risk stratification models for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients that incorporate quantitative ST-segment depression and novel biomarkers...
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul
University of Alberta, 7221 Aberhart Center I, 8440 112 St, Edmonton, AB T6G 2B7, Canada
Circulation 110:1754-60. 2004..4%, adjusted P=0.02). We sought to determine whether Canadian-US differences in practice patterns in GUSTO-I had an impact on 5-year mortality...
Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failureJustin A Ezekowitz
Division of Cardiology, Department of Medicine University of Alberta, Canada
Eur J Heart Fail 10:308-14. 2008..We examined discharge rates, and whether outcomes, including mortality, differed based on admission status in AHF...
Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classificationPadma Kaul
Division of Cardiology, University of Alberta, Edmonton, Alberta T6G 2M8, Canada
Can J Cardiol 25:e225-31. 2009..Despite its widespread use, limited data on the validity of the Canadian Cardiovascular Society angina (CCSA) classification relative to other measures of functional status have been reported...
International differences in evolution of early discharge after acute myocardial infarctionPadma Kaul
University of Alberta, Edmonton, Alberta, Canada
Lancet 363:511-7. 2004..We aimed to identify the extent to which countries have taken advantage of the opportunity for early discharge...
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarctionJustin A Ezekowitz
Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
J Am Coll Cardiol 53:13-20. 2009..The purpose of this study was to examine the long-term incidence of heart failure (HF) in elderly patients with myocardial infarction (MI)...
Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?Justin A Ezekowitz
2C2 Cardiology UAH, University of Alberta, 8440 112 Street, Edmonton, AB T6G 2B7, Canada
Can J Physiol Pharmacol 85:173-8. 2007..This likely reflects the variability in NT-proBNP at presentation and the ability to integrate subsequent important physiologic sequelae of STEMI such as reperfusion and infarct size...
Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-careAlexander M Clark
Faculty of Nursing, Level 3 CSB, University of Alberta, Edmonton, AB, Canada T6R 2R6
Eur J Heart Fail 11:617-21. 2009..We aimed to examine the individual and contextual factors perceived by patients and their informal caregivers' to influence their willingness and capacity to undertake effective HF self-care...
Better outcomes for patients treated at hospitals that participate in clinical trialsSumit R Majumdar
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Arch Intern Med 168:657-62. 2008....
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failureFinlay A McAlister
University of Alberta Hospital, 2F1 21 Walter Mackenzie Health Sciences Centre, 8440 112 Street, Edmonton, Alberta, Canada
Ann Intern Med 150:784-94. 2009..Guidelines recommend that patients with heart failure receive beta-blockers in doses used in the trials that have proven their efficacy. Although the adverse effects of beta-blockade are dose-related, it is unclear whether the benefits are...
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trialCynthia M Westerhout
Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2S2
Am Heart J 154:306-12. 2007....
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz
University of Alberta and the Canadian VIGOUR Center, Edmonton, Alberta, Canada
Am Heart J 160:272-8. 2010....
Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromesPadma Kaul
Division of Cardiology, Department of Medicine, and the Canadian VIGOUR Centre, University of Alberta, Edmonton, Alta
CMAJ 177:1193-9. 2007..We sought to examine sex-related differences at an earlier point in care--presentation to the emergency department...
Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in womenCynthia M Westerhout
Canadian VIGOUR Centre Research Group, 214 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2S2
Eur Heart J 28:2064-9. 2007..To examine the association of left ventricular hypertrophy (LVH) on admission electrocardiography with adverse outcomes in acute coronary syndrome (ACS) patients...
How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohortsFinlay A McAlister
The Division of General Internal Medicine, 2E3 24 Walter Mackenzie Health Sciences Centre, University of Alberta, 8440 112 Street, Edmonton, Alberta T6G 2R7, Canada
Eur Heart J 27:323-9. 2006..To determine what proportion of patients with heart failure are eligible for cardiac resynchronization therapy (CRT)...
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul
University of Alberta, 7, 226 Aberhart Center I, Edmonton, Alberta, Canada T6G 2J3
Eur Heart J 27:1198-206. 2006..To examine the relative contribution of system and patient level factors to the variation in international revascularization rates, and their impact on mortality outcomes...
The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinicJustin A Ezekowitz
Division of Cardiology, University of Alberta, Edmonton, Alberta T6G 2H7
Can J Cardiol 21:165-71. 2005..Accordingly, the relationship among sex, anemia and outcomes in CHF was analyzed...
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort studyFinlay A McAlister
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Circulation 109:1004-9. 2004..The prevalence, prognostic import, and impact of renal insufficiency on the benefits of ACE inhibitors and beta-blockers in community-dwelling patients with heart failure are uncertain...
Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarctionPadma Kaul
Department of Medicine, Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 149:637-44. 2005....
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failureFinlay A McAlister
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
Circulation 113:2572-8. 2006....
Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudyPadma Kaul
University of Alberta, Edmonton
Can J Cardiol 20:760-6. 2004....
A systematic review of randomized trials of disease management programs in heart failureF A McAlister
Divisions of General Internal Medicine, University of Alberta Hospital, Edmonton, Canada
Am J Med 110:378-84. 2001..Data on mortality are inconclusive. Further studies are needed to establish the incremental benefits of the different elements of these programs...
Therapeutic exercise for individuals with heart failure: special attention to older women with heart failureM J Haykowsky
Faculty of Rehabilitation Medicine, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
J Card Fail 10:165-73. 2004....
Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failureF H Khadour
Department of Pharmacology, Cardiovascular Research Group, University of Alberta, Edmonton, Alberta, Canada T6G 2S2
Am J Physiol 275:H1971-8. 1998..Ca2+-independent NOS activity was undetectable in any cardiac tissue. The specific upregulation of eNOS in the left atria suggests that NO production may be enhanced to counterbalance hypertrophy that develops during pacing-induced CHF...
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke
Duke Clinical Research Institute, Durham, NC 27715, USA
Circulation 105:2385-91. 2002..These data lay the foundation for further investigation of factor Xa inhibitors in the treatment of patients with coronary atherothrombosis...
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trialBrahmajee K Nallamothu
University of Michigan Medical Center, Ann Arbor, MI, USA
Eur Heart J 26:1506-12. 2005..CONCLUSION: Peak aPTT levels <50 s and >70 s are associated with worse clinical outcomes in the modern era of fibrinolytic therapy; these relationships are different in patients receiving standard reteplase vs. combination therapy...
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma
University Hospital Rotterdam, Rotterdam, The Netherlands
Lancet 359:189-98. 2002....
